Koninklijke Philips (PHG) Short-Term Debt issuances (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Short-Term Debt issuances of $12.9 million in Q1 2026, up 136.88% quarter-over-quarter from -$34.9 million in Q4 2025, and up 74.9% on a YoY basis from $7.4 million in Q1 2025.
Koninklijke Philips (PHG) Short-Term Debt issuances (2009 - 2026) Analysis & Trends
Koninklijke Philips' Short-Term Debt issuances history runs 18 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- In Q1 2026, Short-Term Debt issuances rose 74.9% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at -$22.4 million (up 81.37% YoY), while the FY2025 annual figure was -$27.9 million, up 12.85% from the prior year.
- Short-Term Debt issuances was $12.9 million for Q1 2026 at Koninklijke Philips, up from -$34.9 million in the prior quarter.
- In the past five years, Short-Term Debt issuances ranged from a high of $66.2 million in Q2 2022 to a low of -$61.4 million in Q2 2024.
- Historically, Short-Term Debt issuances has averaged -$2.2 million across 5 years, with a median of $7.4 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Short-Term Debt issuances sank 325.48% in 2024, then jumped 116.6% in 2025.
- A 5-year view of Short-Term Debt issuances shows it stood at $66.2 million in 2022, then tumbled by 58.85% to $27.2 million in 2023, then tumbled by 217.76% to -$32.1 million in 2024, then retreated by 8.93% to -$34.9 million in 2025, then jumped by 136.88% to $12.9 million in 2026.
- The last three Short-Term Debt issuances figures came in at $12.9 million (Q1 2026), -$34.9 million (Q4 2025), and -$10.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 31.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -1.23 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 12.88 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -1.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 37.80 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.88 Mn |
| Mar 31, 2026 | 12.88 Mn |
| Dec 31, 2025 | -34.92 Mn |
| Dec 31, 2025 | -34.92 Mn |
| Sep 30, 2025 | -10.52 Mn |
| Sep 30, 2025 | -10.52 Mn |
| Jun 30, 2025 | 10.19 Mn |
| Jun 30, 2025 | 10.19 Mn |
| Mar 31, 2025 | 7.36 Mn |
| Mar 31, 2025 | 7.36 Mn |
| Dec 31, 2024 | -32.06 Mn |
| Dec 31, 2024 | -32.06 Mn |
| Sep 30, 2024 | -34.04 Mn |
| Sep 30, 2024 | -34.04 Mn |
| Jun 30, 2024 | -61.38 Mn |
| Jun 30, 2024 | -61.38 Mn |
| Mar 31, 2024 | 24.99 Mn |
| Mar 31, 2024 | 24.99 Mn |
| Jun 30, 2023 | 27.22 Mn |
| Jun 30, 2023 | 27.22 Mn |